Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Embryonic alcohol exposure disrupts the ubiquitin-proteasome system
Olivia Weeks, … , Trista E. North, Wolfram Goessling
Olivia Weeks, … , Trista E. North, Wolfram Goessling
Published December 8, 2022
Citation Information: JCI Insight. 2022;7(23):e156914. https://doi.org/10.1172/jci.insight.156914.
View: Text | PDF
Research Article Development

Embryonic alcohol exposure disrupts the ubiquitin-proteasome system

  • Text
  • PDF
Abstract

Ethanol (EtOH) is a commonly encountered teratogen that can disrupt organ development and lead to fetal alcohol spectrum disorders (FASDs); many mechanisms of developmental toxicity are unknown. Here, we used transcriptomic analysis in an established zebrafish model of embryonic alcohol exposure (EAE) to identify the ubiquitin-proteasome system (UPS) as a critical target of EtOH during development. Surprisingly, EAE alters 20S, 19S, and 11S proteasome gene expression and increases ubiquitylated protein load. EtOH and its metabolite acetaldehyde decrease proteasomal peptidase activity in a cell type–specific manner. Proteasome 20S subunit β 1 (psmb1hi2939Tg) and proteasome 26S subunit, ATPase 6 (psmc6hi3593Tg), genetic KOs define the developmental impact of decreased proteasome function. Importantly, loss of psmb1 or psmc6 results in widespread developmental abnormalities resembling EAE phenotypes, including growth restriction, abnormal craniofacial structure, neurodevelopmental defects, and failed hepatopancreas maturation. Furthermore, pharmacologic inhibition of chymotrypsin-like proteasome activity potentiates the teratogenic effects of EAE on craniofacial structure, the nervous system, and the endoderm. Our studies identify the proteasome as a target of EtOH exposure and signify that UPS disruptions contribute to craniofacial, neurological, and endodermal phenotypes in FASDs.

Authors

Olivia Weeks, Bess M. Miller, Brian J. Pepe-Mooney, Isaac M. Oderberg, Scott H. Freeburg, Colton J. Smith, Trista E. North, Wolfram Goessling

×

Figure 4

Psmb1 and Psmc6 are required for craniofacial and nervous system development.

Options: View larger image (or click on image) Download as PowerPoint
Psmb1 and Psmc6 are required for craniofacial and nervous system develop...
(A) Map of the transgenic insertion sites for psmb1hi2939 and psmc6hi3593 mutants. (B and C) Widefield imaging of psmb1hi2939 and psmc6hi3593 mutants. Both have craniofacial malformations, and psmc6–/– larvae have cardiac edema and blood pooling in the brain (C, white arrowhead). (D and E) Widefield imaging of Alcian blue–stained larvae. (D) psmb1–/– larvae (4 dpf) lack cartilages contributing to the lower jaw and have a reduced ethmoid plate (ep) and abnormal trabecula (t). Cartilage remnants (arrowhead) from the lower jaw appear in a subset of homozygotes. (E) psmc6–/– lack most cranial cartilage. (F–I) Measurements of craniofacial features obtained from ImageJ analysis of Alcian blue–stained larvae (4 dpf; ***P ≤ 0.001, ****P ≤ 0.0001, ordinary 1-way ANOVA with Dunnett’s multiple-comparison test following an observation of a difference in measurements between +/+ and –/– embryos; psmb1+/+, n = 3; psmb1+/–, n = 4; psmb1–/–, n = 4; psmc6+/+, n = 2; psmc6+/–, n = 5; and psmc6–/–, n = 5). (J) Anti-Hu/Anti-tubulin IHC at 72 hpf. psmb1–/– and psmc6–/– have abnormal brain structure and cranial ganglia (white star) and nerve development (white arrowheads). (K) ISH for neurod1 at 72 hpf. psmb1–/– and psmc6–/– have abnormal and missing vagal/cranial ganglia (white arrowheads). Scale bars: 100 μm. Data shown represent mean ± SD.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts